Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03888105 |
|---|---|
| Brief Title: | A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Patients With B-cell Non-Hodgkin Lymphoma That Have Been Previously Treated (ELM-2) |
| First Submitted : | March 14, 2019 |
| First Submitted that Met QC Criteria : | March 20, 2019 |
| First Posted : | March 25, 2019 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 8, 2024 |